CY1114820T1 - Νεες ανοσοενισχυτικες ενωσεις βασιζομενες σε φλαγκελλινη και χρηση αυτων - Google Patents

Νεες ανοσοενισχυτικες ενωσεις βασιζομενες σε φλαγκελλινη και χρηση αυτων

Info

Publication number
CY1114820T1
CY1114820T1 CY20141100101T CY141100101T CY1114820T1 CY 1114820 T1 CY1114820 T1 CY 1114820T1 CY 20141100101 T CY20141100101 T CY 20141100101T CY 141100101 T CY141100101 T CY 141100101T CY 1114820 T1 CY1114820 T1 CY 1114820T1
Authority
CY
Cyprus
Prior art keywords
flaggline
new
immunosuppressant compounds
immunosuppressant
compounds
Prior art date
Application number
CY20141100101T
Other languages
English (en)
Inventor
Jean-Claude Sirard
Original Assignee
Inserm - Institut National De La Santé Et De La Recherche Médicale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inserm - Institut National De La Santé Et De La Recherche Médicale filed Critical Inserm - Institut National De La Santé Et De La Recherche Médicale
Publication of CY1114820T1 publication Critical patent/CY1114820T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αφορά νέες ενώσεις πεπτίδια που λαμβάνονται από φλαγκελλίνη που προέρχεται από Salmonella enterica που δεικνύουν in vivo ανοσοενισχυτική δραστικότητα.
CY20141100101T 2008-06-25 2014-02-06 Νεες ανοσοενισχυτικες ενωσεις βασιζομενες σε φλαγκελλινη και χρηση αυτων CY1114820T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08305327 2008-06-25
EP09769254.5A EP2300609B1 (en) 2008-06-25 2009-06-23 Novel immunoadjuvant flagellin-based compounds and use thereof

Publications (1)

Publication Number Publication Date
CY1114820T1 true CY1114820T1 (el) 2016-12-14

Family

ID=39967832

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100101T CY1114820T1 (el) 2008-06-25 2014-02-06 Νεες ανοσοενισχυτικες ενωσεις βασιζομενες σε φλαγκελλινη και χρηση αυτων

Country Status (20)

Country Link
US (2) US9527891B2 (el)
EP (2) EP2300609B1 (el)
JP (2) JP5756750B2 (el)
KR (1) KR101684447B1 (el)
CN (2) CN103641898B (el)
AU (1) AU2009264257B2 (el)
BR (1) BRPI0914691A2 (el)
CA (1) CA2728038A1 (el)
CY (1) CY1114820T1 (el)
DK (1) DK2300609T3 (el)
EA (1) EA019138B1 (el)
ES (1) ES2445798T3 (el)
HR (1) HRP20140109T1 (el)
IL (1) IL209781A (el)
MX (1) MX2010014575A (el)
PL (1) PL2300609T3 (el)
PT (1) PT2300609E (el)
RS (1) RS53158B (el)
SI (1) SI2300609T1 (el)
WO (1) WO2009156405A1 (el)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9527891B2 (en) * 2008-06-25 2016-12-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Immunoadjuvant flagellin-based compounds and use thereof
EP2536425B1 (en) * 2010-02-18 2019-06-19 Icahn School of Medicine at Mount Sinai Vaccines for use in the prophylaxis and treatment of influenza virus disease
US9708373B2 (en) 2010-03-30 2017-07-18 Icahn School Of Medicine At Mount Sinai Influenza virus vaccine and uses thereof
GB201009273D0 (en) 2010-06-03 2010-07-21 Glaxosmithkline Biolog Sa Novel vaccine
JP5746761B2 (ja) * 2010-06-25 2015-07-08 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 気道感染症の処置のための方法及び医薬組成物
CA2849434A1 (en) 2011-09-20 2013-03-28 Mount Sinai School Of Medicine Influenza virus vaccines and uses thereof
EP2744549A1 (en) * 2011-10-04 2014-06-25 Koninklijke Philips N.V. Forehead gas supply assembly for a patient interface system
GB201120000D0 (en) * 2011-11-20 2012-01-04 Glaxosmithkline Biolog Sa Vaccine
GB201119999D0 (en) * 2011-11-20 2012-01-04 Glaxosmithkline Biolog Sa Vaccine
WO2013177440A2 (en) * 2012-05-23 2013-11-28 The Board Of Trustees Of The Leland Stanford Junior University Ordered flagellin array as an immunostimulant
RU2510281C2 (ru) * 2012-06-22 2014-03-27 Общество с ограниченной ответственностью "Эпитоп" (ООО "Эпитоп") ВАКЦИНА ПРОТИВ ПНЕВМОНИИ, ВЫЗЫВАЕМОЙ Streptococcus pneumoniae, НА ОСНОВЕ ГИБРИДНОГО БЕЛКА
EP4154907A1 (en) 2012-12-18 2023-03-29 Icahn School of Medicine at Mount Sinai Influenza virus vaccines and uses thereof
CN103055311B (zh) * 2012-12-28 2014-05-21 中山大学 一种传染性喉气管炎粘膜疫苗及其制备方法和应用
US9908930B2 (en) 2013-03-14 2018-03-06 Icahn School Of Medicine At Mount Sinai Antibodies against influenza virus hemagglutinin and uses thereof
US9919029B2 (en) * 2013-07-26 2018-03-20 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and pharmaceutical compositions for the treatment of bacterial infections
EP3110401A4 (en) 2014-02-25 2017-10-25 Merck Sharp & Dohme Corp. Lipid nanoparticle vaccine adjuvants and antigen delivery systems
WO2016054696A1 (en) 2014-10-09 2016-04-14 Lipotek Pty Ltd Chimeric proteins
WO2016102536A1 (en) * 2014-12-23 2016-06-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of bacterial superinfections post-influenza
CA2974699A1 (en) 2015-01-23 2016-07-28 Icahn School Of Medicine At Mount Sinai Influenza virus vaccination regimens
CN104610456A (zh) * 2015-01-27 2015-05-13 扬州大学 一种 h7n9 亚型禽流感亚单位疫苗的制备方法及应用
RU2015109715A (ru) * 2015-03-19 2015-08-20 Общество С Ограниченной Ответственностью "Рд-Биотех" (Ооо "Рд-Биотех") ПРОТИВОТУБЕРКУЛЕЗНАЯ ВАКЦИНА НА ОСНОВЕ РЕКОМБИНАНТНЫХ БЕЛКОВ Ag85B, TB10.4, FliC
WO2017218624A1 (en) 2016-06-15 2017-12-21 Icahn School Of Medicine At Mount Sinai Influenza virus hemagglutinin proteins and uses thereof
CN106362144B (zh) * 2016-10-31 2021-02-09 武汉三利生物技术有限公司 呼吸道合胞病毒疫苗
RU2647831C1 (ru) * 2017-03-15 2018-03-19 Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт особо чистых биопрепаратов" Федерального медико-биологического агентства Вакцина против туберкулеза
CA3058652A1 (en) 2017-04-07 2018-10-11 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof
EP3581201A1 (en) 2018-06-15 2019-12-18 GlaxoSmithKline Biologicals S.A. Escherichia coli o157:h7 proteins and uses thereof
AU2019349036A1 (en) 2018-09-27 2021-06-03 Bravovax Co., Ltd Immune composition, preparation method therefor, and application thereof
EP3906047A4 (en) * 2019-01-03 2022-10-05 Nanjing Legend Biotech Co., Ltd. MODIFIED IMMUNE CELLS EXPRESSING A FLAGELLIN POLYPEPTIDE
FR3114970B1 (fr) 2020-10-08 2023-06-30 Univ Tours Combinaison d’anticorps inhalés avec des agents immunomodulateurs pour le traitement ou la prévention d’inféctions respiratoires
CA3202549A1 (en) 2020-12-02 2022-06-09 Glaxosmithkline Biologicals Sa Novel antigens
AU2022208435A1 (en) 2021-01-18 2023-08-10 Conserv Bioscience Limited Coronavirus immunogenic compositions, methods and uses thereof
US20240277801A1 (en) 2021-06-30 2024-08-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Aerosol composition for pulmonary delivery of flagellin
CN114292314B (zh) * 2022-01-05 2022-08-09 武汉科前生物股份有限公司 一种鞭毛素突变体及其在制备非洲猪瘟抗原融合蛋白中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003264724A1 (en) * 2002-09-03 2004-03-29 Fondation Eurovacc Flagellin peptides as adjuvants for vaccines
CA2555253A1 (en) * 2004-02-06 2005-08-25 Yale University Compositions of pamps and listeria monocytogenes and methods of use
WO2005107381A2 (en) * 2004-05-07 2005-11-17 Hans-Gustaf Ljunggren Use of flagellin as an adjuvant for vaccine
WO2006081007A2 (en) * 2004-12-16 2006-08-03 Wake Forest University Health Sciences Use of flagellin in tumor immunotherapy
MY157941A (en) * 2005-01-19 2016-08-15 Vaxinnate Corp Compositions of pathogen-associated molecular patterns and methods of use
WO2009128950A2 (en) 2008-04-18 2009-10-22 Vaxinnate Corporation Deletion mutants of flagellin and methods of use
US9527891B2 (en) * 2008-06-25 2016-12-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Immunoadjuvant flagellin-based compounds and use thereof

Also Published As

Publication number Publication date
WO2009156405A9 (en) 2010-08-19
EP2300609B1 (en) 2013-11-20
MX2010014575A (es) 2011-06-17
EA019138B1 (ru) 2014-01-30
EP2300609A1 (en) 2011-03-30
BRPI0914691A2 (pt) 2015-10-20
JP5756750B2 (ja) 2015-07-29
PT2300609E (pt) 2014-02-17
JP6041851B2 (ja) 2016-12-14
JP2015109837A (ja) 2015-06-18
CN103641898B (zh) 2018-04-17
EP2695941A2 (en) 2014-02-12
CA2728038A1 (en) 2009-12-30
CN102203252A (zh) 2011-09-28
HRP20140109T1 (hr) 2014-03-14
KR20110041479A (ko) 2011-04-21
IL209781A0 (en) 2011-02-28
DK2300609T3 (da) 2014-02-10
PL2300609T3 (pl) 2014-05-30
RS53158B (en) 2014-06-30
CN103641898A (zh) 2014-03-19
WO2009156405A1 (en) 2009-12-30
EA201001820A1 (ru) 2011-08-30
IL209781A (en) 2013-11-28
AU2009264257B2 (en) 2013-11-07
US9527891B2 (en) 2016-12-27
ES2445798T3 (es) 2014-03-05
US20170021015A1 (en) 2017-01-26
SI2300609T1 (sl) 2014-04-30
EP2695941A3 (en) 2014-03-05
KR101684447B1 (ko) 2016-12-08
CN102203252B (zh) 2016-08-03
WO2009156405A8 (en) 2010-03-25
EP2695941B1 (en) 2015-07-29
US9956284B2 (en) 2018-05-01
AU2009264257A1 (en) 2009-12-30
US20110110962A1 (en) 2011-05-12
JP2011525371A (ja) 2011-09-22

Similar Documents

Publication Publication Date Title
CY1114820T1 (el) Νεες ανοσοενισχυτικες ενωσεις βασιζομενες σε φλαγκελλινη και χρηση αυτων
CY1124144T1 (el) Συνθεσεις και μεθοδοι για θεραπεια εγκεφαλικου επεισοδιου σε ενα υποκειμενο επι ταυτοχρονης θεραπειας στατινης
CY1118680T1 (el) Φαρμακευτικη συνθεση
CY1121742T1 (el) Αντισωματα s100a4 και θεραπευτικες χρησεις αυτων
CY1116064T1 (el) Συστασεις αναστολεα ddp iv
CO6551683A2 (es) Tratamiento para trastornos gastrointestinales
CY1114988T1 (el) Βενζοδιαζεπινη αναστολεας bromodomain
CY1115262T1 (el) Ανταγωνιστες trpv1 και χρησεις αυτων
EA201170227A1 (ru) Имидазолкарбоксамиды
CY1115708T1 (el) Τοπικες συνθεσεις για τη διατηρηση ή την ανακτηση της ακεραιοτητας των βλεννογονων
CY1121465T1 (el) Μεθοδοι και συνθεσεις για τη θεραπεια της φλεγμονωδους νοσου του εντερου
CY1118508T1 (el) Συνθεση υδατανθρακων λαμβανομενη απο μεσογειακους καρπους
CY1123490T1 (el) Συνθεσεις που προερχονται απο χιτοζανη
CY1115437T1 (el) Υδροξυμεθυλοκυκλοεξυλαμινες
CY1115994T1 (el) Φαρμακευτικες τυποποιησεις οι οποιες περιεχουν προσδεματα υποδοχεα ντοπαμινης
EA200870514A1 (ru) Ацетиленовые гетероарильные соединения
CY1113485T1 (el) Ενωσεις γεφυρωμενης-πιπεριδινης τυπου υποκατεστημενης-κινοξαλινης και οι χρησεις εξ' αυτων
CY1118710T1 (el) Συνθεσεις για την θεραπεια της πολλαπλης σκληρυνσης
CY1114960T1 (el) Συνθεσεις που περιλαμβανουν τραμαδολη και σελεκοξιμπη στην θεραπεια πονου
CY1117603T1 (el) Η λιξισενατιδη ως προσθετο στη μετφορμινη στην θεραπευτικη αγωγη του διαβητη τυπου 2
MA32349B1 (fr) Antagonistes de la voie hedgehog a base de phtalazines disubstituees
CY1115975T1 (el) Ταπενταδολη για τη θεραπεια πονου σε αρθριτιδα
CY1122998T1 (el) Μεθοδοι και συνθεσεις για την αντιμετωπιση της καταθλιψης χρησιμοποιωντας κυκλοβενζαπρινη
EA200870515A1 (ru) Моноциклические гетероарильные соединения
EA201390799A1 (ru) Триазолопиридины